Holen Sie sich die Stockscreener-App
67.88
0.26%
0.10
Schlusskurs vom Vortag:
$67.78
Offen:
$67.95
24-Stunden-Volumen:
381.93K
Relative Volume:
0.34
Marktkapitalisierung:
$1.94B
Einnahmen:
$267.23M
Nettoeinkommen (Verlust:
$-83.50M
KGV:
-21.83
EPS:
-3.11
Netto-Cashflow:
$-59.99M
1W Leistung:
+6.83%
1M Leistung:
-29.86%
6M Leistung:
-13.66%
1J Leistung:
+239.94%
1-Tages-Spanne:
$67.00
$69.41
1-Wochen-Bereich:
$63.15
$73.57
52-Wochen-Spanne:
$19.16
$117.75
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Vergleichen Sie WGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
67.88 | 1.70B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
401.26 | 153.28B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
188.29 | 134.42B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
507.87 | 40.97B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
110.12 | 32.05B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
138.43 | 24.53B | 15.50B | 1.33B | 2.16B | 7.34 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
GeneDx Breakthrough: How AI Technology is Revolutionizing Genetic Disease Detection - Stock Titan
GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip - Seeking Alpha
GeneDx Holdings Corp (WGS) Shares Up 6.43% on May 16 - GuruFocus
How the (WGS) price action is used to our Advantage - news.stocktradersdaily.com
GeneDx (WGS) Receives Positive Outlook from Guggenheim with Buy Rating | WGS Stock News - GuruFocus
Guggenheim Initiates GeneDx Holdings at Buy With $88 Price Target - marketscreener.com
GeneDx shares tumble 40% after InvestingPro's overvaluation alert By Investing.com - Investing.com South Africa
GeneDx shares tumble 40% after InvestingPro’s overvaluation alert By Investing.com - Investing.com Nigeria
GeneDx: Time To Buy The Dip (NASDAQ:WGS) - Seeking Alpha
GeneDx plunges despite Q1 beat and guidance raise - MSN
GeneDx Holdings stock trades higher as upgraded at Jefferies - MSN
WGS: Key Meeting Announcement by BTIG in San Francisco | WGS Sto - GuruFocus
GeneDx upgraded to Buy from Hold on growth outlook - MSN
GeneDx Shares Rise After Ratings Upgrade From Jefferies - marketscreener.com
GeneDx Holdings (WGS) Upgraded by Jefferies on Growth Prospects - GuruFocus
GeneDx (WGS) Upgraded by Jefferies Amid Growth Prospects - GuruFocus
GeneDx stock upgraded at Jefferies on outlook (WGS:NASDAQ) - Seeking Alpha
Analyst Expectations For GeneDx Holdings's Future - Benzinga
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga
Jefferies Upgrades GeneDx Holdings (WGS) - Nasdaq
Jefferies Upgrades GeneDx to Buy From Hold, $80 Price Target - marketscreener.com
GeneDx upgraded to Buy from Hold at Jefferies - TipRanks
GeneDx completes acquisition of Fabric Genomics - Yahoo Finance
GeneDx Holdings Corp. completed the acquisition of Fabric Genomics, Inc. - marketscreener.com
GeneDx Holdings Becomes Oversold (WGS) - Nasdaq
GeneDx Announces Completion of Fabric Genomics Acquisition - Business Wire
Envestnet Asset Management Inc. Purchases New Shares in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
Where are the Opportunities in (WGS) - news.stocktradersdaily.com
Best Momentum Stocks to Buy for May 5th - The Globe and Mail
Best Momentum Stocks To Buy For May 5th - Barchart.com
New Strong Buy Stocks for May 5th - Yahoo Finance
Why Investors Were Avoiding GeneDx Holdings Stock This Week - AOL.com
Stamford genetic-testing firm GeneDx still searching for tenants to sublet part of HQ, shuttered CT lab spaces - Hartford Business Journal
With A 26% Price Drop For GeneDx Holdings Corp. (NASDAQ:WGS) You'll Still Get What You Pay For - simplywall.st
GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why - MSN
GeneDx Holdings (WGS) Gets a Hold from Wells Fargo - The Globe and Mail
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates - MSN
GeneDx price target lowered to $78 from $105 at Wells Fargo - TipRanks
GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fa - GuruFocus
GeneDx price target lowered to $100 from $115 at BTIG - TipRanks
GeneDx Holdings (WGS) Price Target Lowered by TD Securities | WG - GuruFocus
GeneDx stock target cut to $100 by BTIG, maintains Buy rating - Investing.com Nigeria
GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fargo | WGS Stock News - GuruFocus
GeneDx earnings selloff a buying opportunity, says Craig-Hallum - Yahoo Finance
GeneDx (WGS) Price Target Reduced by TD Cowen Amid Strong Perfor - GuruFocus
GeneDx (WGS) Price Target Reduced by TD Cowen Amid Strong Performance | WGS Stock News - GuruFocus
GeneDx (WGS) Stock Decline Seen as Buying Opportunity | WGS Stoc - GuruFocus
GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2025 Earnings Call Transcript - Insider Monkey
GeneDx (WGS) Sees Price Target Cut But Retains Buy Rating | WGS Stock News - GuruFocus
Wells Fargo Adjusts Price Target for GeneDx (WGS) Amid Market Fl - GuruFocus
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Meister Keith A. | Director |
May 08 '25 |
Buy |
56.01 |
100,000 |
5,600,994 |
3,008,629 |
| PFENNIGER RICHARD C JR | Director |
May 02 '25 |
Option Exercise |
0.00 |
918 |
0 |
28,582 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 29 '25 |
Option Exercise |
0.00 |
753 |
0 |
3,725 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Apr 29 '25 |
Sale |
113.09 |
388 |
43,879 |
3,337 |
| Stueland Katherine | Chief Executive Officer |
Apr 29 '25 |
Option Exercise |
0.00 |
3,874 |
0 |
5,594 |
| Stueland Katherine | Chief Executive Officer |
Apr 29 '25 |
Sale |
113.09 |
2,154 |
243,596 |
3,440 |
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):